You have 9 free searches left this month | for more free features.

hypoproliferative thrombocytopenia

Showing 1 - 25 of 634

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hypoproliferative Thrombocytopenia Trial in Singapore (Control arm receiving normal (never before frozen) platelets as per

Completed
  • Hypoproliferative Thrombocytopenia
  • Control arm receiving normal (never before frozen) platelets as per current clinical practice
  • Treatment arm receiving cryopreserved platelets
  • Singapore, Singapore
    Singapore General Hospital
Sep 23, 2021

Hematologic Malignancies, Hypoproliferative Thrombocytopenia Trial in United States (Mirasol platelets (MIR PLTs), Reference

Terminated
  • Hematologic Malignancies
  • Hypoproliferative Thrombocytopenia
  • Mirasol platelets (MIR PLTs)
  • Reference platelets (REF PLTs)
  • Washington, District of Columbia
  • +9 more
Jul 28, 2021

ROTEM and Platelet Indices in Thrombocytopenic Patients .

Not yet recruiting
  • Patients With Low Platelets Counts
    • (no location specified)
    Apr 29, 2023

    Chemo-induced Thrombocytopenia Trial in Shanghai (QL0911)

    Completed
    • Chemotherapy-induced Thrombocytopenia
    • Shanghai, Shanghai, China
      Shanghai East Hospital
    May 5, 2023

    Thrombopoietin Agonists in Idiopathic Thrombocytopenic Purpura

    Not yet recruiting
    • ITP - Immune Thrombocytopenia
    • eltrombopag and romiplastim
    • (no location specified)
    Nov 16, 2023

    Thrombocytopenia Trial (Hetrombopag)

    Not yet recruiting
    • Thrombocytopenia
    • (no location specified)
    Sep 7, 2023

    Chemo-induced Thrombocytopenia Trial in Shanghai (QL0911, Placebo)

    Recruiting
    • Chemotherapy-induced Thrombocytopenia
    • Shanghai, Shanghai, China
      Shanghai East Hospital
    Sep 21, 2022

    Outcome of Thrombocytopenia in ICU Patients

    Not yet recruiting
    • Thrombocytopenia
      • (no location specified)
      Jul 15, 2023

      Thrombocytopenia Purpura, Chronic HBV Infection Trial in Tianjin (Eltrombopag)

      Completed
      • Thrombocytopenia Purpura
      • Chronic HBV Infection
      • Tianjin, Tianjin, China
        Ethics Committee of Blood disease hospital, Chinese Academy of M
      Jan 24, 2023

      Study of Severe Fever With Thrombocytopenia Syndrome

      Recruiting
      • Severe Fever With Thrombocytopenia Syndrome
        • Guangshui, Hubei, China
        • +7 more
        Aug 21, 2023

        Myelofibrosis Trial in Saint Louis (Fostamatinib, Ruxolitinib)

        Recruiting
        • Myelofibrosis
        • Saint Louis, Missouri
          Washington University School of Medicine
        Oct 26, 2022

        Ketogenic Diet Trial (Strict ketogenic diet group, Cyclic ketogenic diet group, Autonomous ketogenesis group)

        Not yet recruiting
        • Ketogenic Diet
        • Strict ketogenic diet group
        • +2 more
        • (no location specified)
        Oct 26, 2023

        Systemic Lupus Erythematosus Trial (Telitacicept, conventional therapy, Placebo)

        Not yet recruiting
        • Systemic Lupus Erythematosus
        • (no location specified)
        Jun 26, 2023

        Connective Tissue Diseases, Thrombocytopenia Trial in China (Telitacicept, Placebo)

        Not yet recruiting
        • Connective Tissue Diseases
        • Thrombocytopenia
        • Telitacicept
        • Placebo
        • Hefei, Anhui, China
        • +21 more
        Aug 18, 2023

        Chronic Primary Immune Thrombocytopenia (ITP) Trial in China (Qrelabrutinib, Placebo)

        Not yet recruiting
        • Chronic Primary Immune Thrombocytopenia (ITP)
        • Bengbu, Anhui, China
        • +13 more
        Aug 15, 2023

        Chemo-Induced Thrombocytopenia Trial (Hetrombopag)

        Not yet recruiting
        • Chemotherapy-Induced Thrombocytopenia
        • (no location specified)
        Jul 24, 2023

        Clinical Performance Evaluation of T-TASĀ®01 HD Chip

        Recruiting
        • Thrombocytopenia
        • T-TAS 01 HD Assay
        • San Francisco, California
        • +5 more
        Oct 11, 2023

        Immune Thrombocytopenia, Treatment Trial in Tianjin (Obinutuzumab Injection [Gazyva])

        Not yet recruiting
        • Immune Thrombocytopenia
        • Treatment
        • Obinutuzumab Injection [Gazyva]
        • Tianjin, China
          Chinese Academy of Medical Science and Blood Disease Hospital
        Aug 9, 2023

        Chemo-Induced Thrombocytopenia Trial (Hetrombopag Olamine)

        Not yet recruiting
        • Chemotherapy-Induced Thrombocytopenia
        • Hetrombopag Olamine
        • (no location specified)
        Jul 5, 2023

        Immune Thrombocytopenia, Treatment Trial in Tianjin (Obinutuzumab Injection [Gazyva])

        Not yet recruiting
        • Immune Thrombocytopenia
        • Treatment
        • Obinutuzumab Injection [Gazyva]
        • Tianjin, China
          Institute of Hematology and Blood Diseases Hospital, Chinese Aca
        Oct 17, 2023

        Chemo-induced Thrombocytopenia, Eltrombopag Trial in Tianjin (Eltrombopag)

        Recruiting
        • Chemotherapy-induced Thrombocytopenia
        • Eltrombopag
        • Tianjin, Tianjin, China
          Chinese Academy of Medical Science and Blood Disease Hospital
        Jan 24, 2023

        Chemo-induced Thrombocytopenia, Herombopag Trial in Tianjin (Herombopag)

        Recruiting
        • Chemotherapy-induced Thrombocytopenia
        • Herombopag
        • Tianjin, Tianjin, China
          Chinese Academy of Medical Science and Blood Disease Hospital
        Jan 24, 2023

        Chemo-induced Thrombocytopenia, Avatrombopag Trial in Tianjin (Avatrombopag)

        Recruiting
        • Chemotherapy-induced Thrombocytopenia
        • Avatrombopag
        • Tianjin, Tianjin, China
          Chinese Academy of Medical Science and Blood Disease Hospital
        Jan 24, 2023

        Chemo-Induced Thrombocytopenia Trial (Hetrombopag, Hetrombopag plus Placebo, Placebo)

        Not yet recruiting
        • Chemotherapy-Induced Thrombocytopenia
        • (no location specified)
        May 17, 2023

        Thrombocytopenia, Hepatocellular Carcinoma Trial in Guangzhou (Avatrombopag)

        Not yet recruiting
        • Thrombocytopenia
        • Hepatocellular Carcinoma
        • Guangzhou, Guangdong, China
          The Second Affiliated Hospital of Guangzhou Medical University
        Aug 17, 2023